Search for: "PFIZER" Results 3061 - 3080 of 4,635
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Oct 2016, 4:16 am by Dan Harris
Pfizer’s subsequent attempt to re-brand Viagra from the name it was already called in China (伟哥, or “Weige”) to its preferred choice (万艾可, or “Wan’aike”) was doomed from the start, as evidenced by a series of expensive court cases that Pfizer kept losing. [read post]
24 Jan 2022, 1:44 pm by divi
Those who passed on Theranos’ hot, once-in-a-lifetime opportunity include: Pfizer: Shane Weber, a Pfizer director, in 2008 looked into Theranos and found their responses to his technical questions were “oblique, deflective or evasive,” according to a memo used as evidence during Holmes’ trial. [read post]
19 Mar 2012, 3:57 am by Max Kennerly, Esq.
For Zoloft, although manufactured by Pfizer, most of the informational materials included with it are actually written and published by Wolters Kluwer Health. [read post]
28 Oct 2009, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) - US: District Court S D New York finds Teva infringed Alcon's patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) - US: District Court Delaware rules that… [read post]
2 Nov 2009, 7:11 am
Roberts, Jr., took no part in the order, perhaps because he owns Pfizer stock. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
FDA provided each Boehringer and Pfizer the opportunity to present its interpretation of FIE expiration provisions, but FDA ultimately “decline[d] to adopt either Pfizer’s or BI’s proposed interpretation. [read post]
19 Jan 2011, 2:00 am by Kelly
(Spicy IP) India: Delhi Patent Office refuses Warner-Lambert’s application claiming topical formulation of Pfizer’s potential potassium channel opener for treatment of alopecia (ipfeathers) India: Chennai Patent Office refuses Novartis’ application claiming mixture of anti-oxidant with oxidation sensitive macrolide everolimus (ipfeathers) Kenya: High Court enjoins UN in case against generic ARVs ban (GenericsWeb) US government urges WHO to support Medicines Patent Pool:… [read post]
15 May 2019, 5:27 am by Kluwer Patent blogger
Besides Teva, also Sandoz, Novartis, Mylan and Pfizer are mentioned, among others. [read post]
17 Sep 2020, 4:55 am by Bob Ambrogi
In Heller’s brief-drafting demonstration on Tuesday, he pretended he was representing drug manufacturer Pfizer in a lawsuit brought by a salesperson working as an independent contractor. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
17 Jan 2012, 8:10 am by Lovechilde
’s, whose five-year tenure as CEO of Pfizer was marked by a $140 billion drop in Pfizer’s stock market value. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
”  MSD appealed the case to the Supreme Court, but the appeal was fully withdrawn on September 22, 2021, as Pfizer and MSD entered into a worldwide settlement and license agreement wherein MSD agreed to make certain regulatory milestone payments and royalty payments to Pfizer for the sale of its pneumococcal conjugate vaccine products. [read post]
28 Oct 2009, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) - US: District Court S D New York finds Teva infringed Alcon's patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) - US: District Court Delaware rules that… [read post]
”  MSD appealed the case to the Supreme Court, but the appeal was fully withdrawn on September 22, 2021, as Pfizer and MSD entered into a worldwide settlement and license agreement wherein MSD agreed to make certain regulatory milestone payments and royalty payments to Pfizer for the sale of its pneumococcal conjugate vaccine products. [read post]
2 Feb 2012, 8:53 pm by Bexis
Pfizer (Bextra)     Deposition 2008-03-17 Haslam v. [read post]
22 Jun 2014, 9:01 pm by Ronald D. Rotunda
The tax lawyers for Pfizer must be earning their keep. [read post]